Cross-institution positioning
Mar 26, 2026Strong institutional reduction. 1 reducing, 4 exited across 5 comparable institutions.
Source: Schedule 13 researchPhreesia, Inc.
Latest stored close $10.81 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 1 reducing, 4 exited across 5 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 4 sales by 3 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; 1 capital-related filing/event; Latest classified evidence: Shelf securities registration. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +10.4% YoY; Net income +193.3% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 15% through its reported 52-week range; -55.7% over one year.
Source: Stored historical price seriesFiled Mar 26, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Hoffman Allison C | SOpen-market or private sale | Common Stock | 6.7K | $10.08 | Direct | Sep 22, 2026 |
| Sep 18, 2026 | Hoffman Allison C | FTax/price withholding or payment | Common Stock | 7.4K | $10.42 | Direct | Sep 22, 2026 |
| Sep 18, 2026 | Linetsky David | FTax/price withholding or payment | Common Stock | 319 | $10.42 | Indirect | Sep 22, 2026 |
| Sep 18, 2026 | Linetsky David | FTax/price withholding or payment | Common Stock | 4.5K | $10.42 | Direct | Sep 22, 2026 |
| Sep 18, 2026 | Roberts Evan | FTax/price withholding or payment | Common Stock | 4.5K | $10.42 | Direct | Sep 22, 2026 |
| Sep 18, 2026 | VanDuyn Amy Beth | FTax/price withholding or payment | Common Stock | 2.9K | $10.42 | Direct | Sep 22, 2026 |
| Sep 14, 2026 | Hoffman Allison C | AGrant, award, or other acquisition | Common Stock | 14.1K | $0.00 | Direct | Sep 16, 2026 |
| Sep 14, 2026 | VanDuyn Amy Beth | AGrant, award, or other acquisition | Common Stock | 6.5K | $0.00 | Direct | Sep 16, 2026 |
| Sep 14, 2026 | Linetsky David | AGrant, award, or other acquisition | Common Stock | 703 | $0.00 | Indirect | Sep 16, 2026 |
| Sep 14, 2026 | Linetsky David | AGrant, award, or other acquisition | Common Stock | 8.1K | $0.00 | Direct | Sep 16, 2026 |
| Sep 14, 2026 | Roberts Evan | AGrant, award, or other acquisition | Common Stock | 8.1K | $0.00 | Direct | Sep 16, 2026 |
| Sep 1, 2026 | Gandhi Balaji | AGrant, award, or other acquisition · derivative | Performance Stock Units | 155.0K | $0.00 | Direct | Sep 28, 2026 |
| Sep 1, 2026 | Hoffman Allison C | AGrant, award, or other acquisition · derivative | Performance Stock Units | 85.0K | $0.00 | Direct | Sep 28, 2026 |
| Sep 1, 2026 | Hui Yvonne | AGrant, award, or other acquisition · derivative | Performance Stock Units | 28.5K | $0.00 | Direct | Sep 28, 2026 |
| Sep 1, 2026 | Indig Chaim | AGrant, award, or other acquisition · derivative | Performance Stock Units | 400.0K | $0.00 | Direct | Sep 28, 2026 |
| Sep 1, 2026 | Linetsky David | AGrant, award, or other acquisition · derivative | Performance Stock Units | 155.0K | $0.00 | Direct | Sep 28, 2026 |
| Sep 1, 2026 | Roberts Evan | AGrant, award, or other acquisition · derivative | Performance Stock Units | 155.0K | $0.00 | Direct | Sep 28, 2026 |
| Sep 1, 2026 | VanDuyn Amy Beth | AGrant, award, or other acquisition · derivative | Performance Stock Units | 67.5K | $0.00 | Direct | Sep 28, 2026 |
| Sep 1, 2026 | Gandhi Balaji | AGrant, award, or other acquisition | Common Stock | 192.0K | $0.00 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | Hoffman Allison C | AGrant, award, or other acquisition | Common Stock | 108.0K | $0.00 | Direct | Sep 3, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 3, 2026 | S-3ASR | — | Shelf securities registration | Capital-related | Filing |
| Sep 2, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jun 24, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| May 27, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 11, 2026 | 8-K | 8.01 | Other event | — | Filing |
| May 4, 2026 | 8-K | 1.01, 2.03 | Material definitive agreement; New direct financial obligation | Debt | Filing |
| Apr 3, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Mar 31, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Mar 30, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Mar 16, 2026 | 8-K | 1.01, 1.02, 2.03, 7.01, 9.01 | Material definitive agreement; Termination of material agreement; New direct financial obligation; Regulation FD disclosure; Financial statements / exhibits | Debt | Filing |
| Feb 23, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jan 28, 2026 | 8-K/AAmendment | 9.01 | Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jul 31, 2026 | $129.5M | +10.4% |
| Ended Apr 30, 2026 | $130.9M | +12.9% |
| Ended Oct 31, 2025 | $120.3M | +12.7% |
| Ended Jul 31, 2025 | $117.3M | +14.8% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Jan 31, 2026 | $467.8M | +14.0% |
| Ended Jan 31, 2025 | $410.5M | +18.6% |
| Ended Jan 31, 2024 | $346.0M | +23.2% |
| Ended Jan 31, 2023 | $280.9M | +31.7% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 26, 2026 filed · 13d Schedule 13G amendment | Exit below reporting threshold | 0 -6.1M | 0.00% -10.09 pts | $10.97 | $11.65 | $10.81 |
| Vanguard Group CIK0000102909 | Jan 30, 2026 observed Feb 5, 2026 filed · 6d Schedule 13G amendment | Reported accumulation | 6.1M +378.4K | 10.09% +0.57 pts | $13.43 | $12.59 | $10.81 |
| Fidelity / FMR CIK0000315066 | Dec 31, 2025 observed Jan 8, 2026 filed · 8d Schedule 13G amendment | Exit below reporting threshold | 363.0K +359.1K | 0.60% -5.90 pts | $16.92 | $16.90 | $10.81 |
Compare PHR with other securities showing similar institutional activity or recent accumulation across several tracked institutions.